For US Healthcare Professionals

Mechanism of disease

Actor portrayal

Mechanism of disease

The role of hepatic lactate dehydrogenase (LDH) in the excessive overproduction of oxalate in PH

The role of hepatic lactate dehydrogenase (LDH) in the excessive overproduction of oxalate in PH

See what causes primary hyperoxaluria (PH) by watching the video below.

In the glyoxylate metabolic pathway, glyoxylate is normally recycled by a number of different enzymes in the hepatocyte.1,2

Normal glyoxylate metabolic pathway1,2

Normal glyoxylate metabolic pathway graphic
Normal glyoxylate metabolic pathway graphic

Touch image for larger view

In the 3 genetically defined subtypes of PH, a defect in 1 of 3 liver enzymes causes a deficiency in the glyoxylate metabolic pathway, resulting in the overproduction of glyoxylate.1-6

Dysregulated glyoxylate metabolic pathway1

Dysregulated glyoxylate metabolic pathway graphic
Dysregulated glyoxylate metabolic pathway graphic

Touch image for larger view

In PH1, PH2, and PH3, hepatic LDH catalyzes the final common step in this pathway, converting abnormally high glyoxylate into excessive oxalate6

PH1

AGT enzyme deficiency

PH2

GRHPR enzyme deficiency

PH3

HOGA enzyme deficiency

Stay educated

Stay up to date with the latest news and information about primary hyperoxaluria.

Sign up

References

  1. Martin-Higueras C et al. Molecular therapy of primary hyperoxaluria. J Inherit Metab Dis. 2017;40(4):481-489.
  2. Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649-658.
  3. Belostotsky R et al. Primary hyperoxaluria type III—a model for studying perturbations in glyoxylate metabolism. J Mol Med (Berl). 2012;90(12):1497-1504.
  4. Riedel TJ et al. 4-hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. Biochim Biophys Acta. 2012;1822(10):1544-1552.
  5. Ben-Shalom E, Frishberg Y. Primary hyperoxalurias: diagnosis and treatment. Pediatr Nephrol. 2015;30(10):1781-1791.
  6. Lai C et al. Specific inhibition of hepatic lactate dehydrogenase reduces oxalate production in mouse models of primary hyperoxaluria. Mol Ther. 2018;26(8):1983-1995.

You are about to leave UncoveringPH.com, a Novo Nordisk website.

You have selected to view information that is intended for US healthcare professionals only. By clicking “Continue,” you certify that you are a US healthcare professional. Click "Cancel" to stay and learn more about primary hyperoxaluria.

Continue

You are about to leave UncoveringPH.com, a Novo Nordisk website.

Click "Continue" to leave this site. Novo Nordisk is not responsible for the content of the site you are about to visit. Click "Cancel" to stay and learn more about primary hyperoxaluria (PH).

Continue